Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR.
Mitsuoka S, Kawaguchi T, Kubo A, Isa S, Asai K, Uji M, Watanabe T, Sawa K, Yoshimoto N, Oka T, Nakai T, Suzumura T, Tanaka H, Matsuura K, Kimura T, Yoshimura N, Kudoh S, Hirata K. Mitsuoka S, et al. Among authors: kawaguchi t. Expert Opin Pharmacother. 2016;17(2):193-203. doi: 10.1517/14656566.2016.1109635. Epub 2016 Jan 18. Expert Opin Pharmacother. 2016. PMID: 26781399 Review.
Epidermal growth factor receptor gene amplification and gefitinib sensitivity in patients with recurrent lung cancer.
Sasaki H, Endo K, Okuda K, Kawano O, Kitahara N, Tanaka H, Matsumura A, Iuchi K, Takada M, Kawahara M, Kawaguchi T, Yukiue H, Yokoyama T, Yano M, Fujii Y. Sasaki H, et al. Among authors: kawaguchi t. J Cancer Res Clin Oncol. 2008 May;134(5):569-77. doi: 10.1007/s00432-007-0320-z. Epub 2007 Oct 12. J Cancer Res Clin Oncol. 2008. PMID: 17932690
EGFR polymorphism of the kinase domain in Japanese lung cancer.
Sasaki H, Endo K, Takada M, Kawahara M, Tanaka H, Kitahara N, Matsumura A, Iuchi K, Kawaguchi T, Okuda K, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y. Sasaki H, et al. Among authors: kawaguchi t. J Surg Res. 2008 Aug;148(2):260-3. doi: 10.1016/j.jss.2007.09.001. Epub 2007 Oct 5. J Surg Res. 2008. PMID: 18541260
EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.
Sasaki H, Okuda K, Shimizu S, Takada M, Kawahara M, Kitahara N, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Kubo A, Kawano O, Yukiue H, Yano M, Fujii Y. Sasaki H, et al. Among authors: kawaguchi t. J Cancer Res Clin Oncol. 2009 Feb;135(2):313-8. doi: 10.1007/s00432-008-0464-5. Epub 2008 Aug 23. J Cancer Res Clin Oncol. 2009. PMID: 18726117
2,574 results